KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Non-Current Deffered Revenue (2018 - 2022)

Tenet Healthcare's Non-Current Deffered Revenue history spans 3 years, with the latest figure at $13.0 million for Q4 2022.

  • For Q4 2022, Non-Current Deffered Revenue fell 13.33% year-over-year to $13.0 million; the TTM value through Dec 2022 reached $13.0 million, down 13.33%, while the annual FY2022 figure was $13.0 million, 13.33% down from the prior year.
  • Non-Current Deffered Revenue for Q4 2022 was $13.0 million at Tenet Healthcare, down from $14.0 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $819.0 million in Q4 2020 and bottomed at $13.0 million in Q4 2022.
  • The 3-year median for Non-Current Deffered Revenue is $15.0 million (2021), against an average of $144.3 million.
  • The largest annual shift saw Non-Current Deffered Revenue plummeted 98.17% in 2021 before it fell 6.67% in 2022.
  • A 3-year view of Non-Current Deffered Revenue shows it stood at $819.0 million in 2020, then tumbled by 98.17% to $15.0 million in 2021, then dropped by 13.33% to $13.0 million in 2022.
  • Per Business Quant, the three most recent readings for THC's Non-Current Deffered Revenue are $13.0 million (Q4 2022), $14.0 million (Q3 2022), and $14.0 million (Q2 2022).